Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Bibliografiske detaljer
Main Authors:	Sinadinos, A, Sergijenko, A, Meng, C, Gamlin, T, Hyde, S, Gill, DR, Griesenbach, U, Alton, EWFW
Format:	Conference item
Sprog:	English
Udgivet:	Cell Press 2021

Lignende værker

Development of protocols for mouse GLP-toxicology studies
af: Sinadinos, A, et al.
Udgivet: (2020)

597: Protocol development for mouse toxicology studies using lentiviral gene therapy
af: Sinadinos, A, et al.
Udgivet: (2021)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
af: Sergijenko, A, et al.
Udgivet: (2021)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
af: Sergijenko, A, et al.
Udgivet: (2020)

Gene therapy for respiratory diseases; progress and a changing context
af: Alton, EWFW, et al.
Udgivet: (2020)

Low titer lentiviral transgenesis in rodents with simian immundeficiency virus vector
af: Balázs Bender, et al.
Udgivet: (2013-09-01)

Lung-targeted lentiviral vector mediates passive immunisation against influenza
af: Tan, T, et al.
Udgivet: (2018)

Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression
af: Helena Lund-Palau, et al.
Udgivet: (2022-06-01)

Lung-targeting lentiviral vector for passive immunisation against influenza
af: Tan, TK, et al.
Udgivet: (2020)

Cholesterol as an enhancer of lentiviral vector production in serum-free transient transfection
af: Gelinas, J, et al.
Udgivet: (2013)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
af: Gélinas, J, et al.
Udgivet: (2017)

Rapid determination of rSIV.F/HN lentiviral vector titre
af: Conway, CC, et al.
Udgivet: (2020)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
af: Sinadinos, A, et al.
Udgivet: (2020)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
af: Ashworth, R, et al.
Udgivet: (2018)

Lentiviral Vector Bioprocessing
af: Christopher Perry, et al.
Udgivet: (2021-02-01)

Production of lentiviral vectors
af: Otto-Wilhelm Merten, et al.
Udgivet: (2016-01-01)

Advances of Lentiviral Vectors
af: Fanrong MENG, et al.
Udgivet: (2014-12-01)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
af: Munday, R, et al.
Udgivet: (2018)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
af: Munday, R, et al.
Udgivet: (2019)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
af: Antepowicz, A, et al.
Udgivet: (2021)

The very stable lentiviral vector
af: Gwendolyn K. Binder, et al.
Udgivet: (2024-03-01)

Special Issue “Lentiviral Vectors”
af: Yasuhiro Takeuchi
Udgivet: (2022-07-01)

The Inside Out of Lentiviral Vectors
af: Stéphanie Durand, et al.
Udgivet: (2011-02-01)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
af: Agata Antepowicz, et al.
Udgivet: (2021-08-01)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
af: Griesenbach, U, et al.
Udgivet: (2011)

Enhanced lentiviral production through rational design of mammalian host cells
af: Hyde, S, et al.
Udgivet: (2016)

Lentiviral Vectors for Ocular Gene Therapy
af: Yvan Arsenijevic, et al.
Udgivet: (2022-07-01)

Comparison of lentiviral vector titration methods
af: Debyser Zeger, et al.
Udgivet: (2006-07-01)

An Improved Protocol for the Production of Lentiviral Vectors
af: Logan Y. Brown, et al.
Udgivet: (2020-12-01)

Rev-dependent lentiviral expression vector
af: Beddall Margaret H, et al.
Udgivet: (2007-02-01)

Effective gene therapy with nonintegrating lentiviral vectors.
af: Yáñez-Muñoz, R, et al.
Udgivet: (2006)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
af: Inès Dufait, et al.
Udgivet: (2012-01-01)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
af: Massimo Conese, et al.
Udgivet: (2010-01-01)

Lentiviral Vector Gene Transfer to Porcine Airways
af: Patrick L Sinn, et al.
Udgivet: (2012-01-01)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
af: Munday, RJ, et al.
Udgivet: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
af: Munday, RJ, et al.
Udgivet: (2022)

Moving lentiviral-based gene therapy into a first-in-man CF trial
af: Griesenbach, D, et al.
Udgivet: (2015)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
af: Alton, E, et al.
Udgivet: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
af: Alton, E, et al.
Udgivet: (2014)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
af: Munday, RJ, et al.
Udgivet: (2022)